Spicogen vaccine to begin human testing in Iran

TEHRAN – The second and third phases of clinical studies of the Iranian-Australian Spicogen vaccine for coronavirus will be performed in Iran, Iranian Food and Drug Administration spokesman Kianoush Jahanpour said.